New hope for resistant breast cancer: experimental pill shows promise in early trial
NCT ID NCT06702618
First seen Apr 11, 2026 · Last updated May 21, 2026 · Updated 2 times
Summary
This phase 2 trial tests a new oral drug (TQB3616) combined with hormone therapy for people with a common type of breast cancer (HR-positive, HER2-negative) that has stopped responding to standard CDK4/6 inhibitor pills. The study enrolls 33 adults whose cancer has returned or spread. The main goal is to see how many patients' tumors shrink or disappear, while also tracking how long the benefit lasts and any side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cancer Hospital of Shandong First Medical University(Shandong Cancer Institute, Shandong Cancer Hospital)
Jinan, Shandong, 250117, China
-
Hai'an People's Hospital
Nantong, Jiangsu, 226600, China
-
Harbin Medical University Cancer Hostipal
Harbin, Heilongjiang, 150000, China
-
Hunan Cancer Hospital
Changsha, Hunan, 410010, China
-
Jiangmen Central Hospital
Jiangmen, Guangdong, 529000, China
-
Jiangsu Provincial People's Hospital
Nanjing, Jiangsu, 210003, China
-
Liaoning Cancer Hospital
Shenyang, Liaoning, 110000, China
-
Luohe Central Hospital
Luohe, Henan, 462000, China
-
The Affiliated Hospital of Southwest Medical University
Luzhou, Sichuan, 646000, China
-
The First Affiliated Hospital of Xi'an Jiao Tong University
Xi’an, Shanxi, 710061, China
-
The First Affilliated Hospital of Bengbu Medical University
Bengbu, Anhui, 233000, China
-
Tianjin Medical University Cancer Institute & Hospital
Tianjin, Tianjin Municipality, 300202, China
-
Xingtai People's Hospital
Xingtai, Hebei, 54000, China
Conditions
Explore the condition pages connected to this study.